Dibenz[b,e]oxepin compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514305, 514382, 514450, 544366, 544378, 546134, 548252, 549354, A61K 31495, C07D40504

Patent

active

045968047

ABSTRACT:
A dibenz[b,e]oxepin compound having an antiallergic activity is represented by the following general formula: ##STR1## wherein R.sub.1 represents a cyano group, a 5-tetrazolyl group, a carbamoyl group or --CO.sub.2 R.sub.3 wherein R.sub.3 represents a hydrogen atom, an alkyl group having 1 to 5 carbon atoms or a 1-(ethoxycarbonyloxy)ethyl group, and R.sub.2 represents a 4-alkylpiperazino group wherein the alkyl group has 1 to 5 carbon atoms, a 3-quinuclidinylamino group or --X--(CH.sub.2).sub.n --NR.sub.4 R.sub.5 wherein X represents --NH--, --S -- or --O--, R.sub.4 and R.sub.5 are same or different and each represents an alkyl group having 1 to 5 carbon atoms and n represents 2 or 3; and the pharmaceutically acceptable acid addition salts or metal salts thereof.

REFERENCES:
patent: 3509176 (1970-04-01), Winter et al.
patent: 4011222 (1977-03-01), Gerecke et al.
patent: 4032525 (1977-06-01), Gerecke et al.
patent: 4144337 (1979-03-01), Bastian

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Dibenz[b,e]oxepin compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dibenz[b,e]oxepin compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dibenz[b,e]oxepin compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2085453

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.